Collection of MNCs and progenitor cells by two separators for PBPC transplantation: A randomized crossover trial

Transfusion

Volumn 43, Issue 6, 2003, Pages 814-819

  Ikeda, Kazuhiko ^b   Ohto, Hitoshi ^a   Nemoto, Kenji ^b   Yamamoto, Go ^b   Kato, Katsuhiko ^b   Ogata, Takashi ^b   Shichishima, Tsutomu ^b   Maruyama, Yukio ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; BLOOD CELL COUNT; BLOOD DONOR; CELL SEPARATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; MONONUCLEAR CELL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; BLOOD COMPONENT REMOVAL; CELL SEPARATION; CROSS-OVER STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; THROMBOCYTOPENIA;

EID: 0038012550     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00422.x     Document Type: Article

References (10)

1. + cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000;18:1360-77.
2. Snyder EL, Baril L, Cooper DL, et al. In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation. Transfusion 2000;40:961-7.
3. Hartmann O, Le Corroller AG, Blaise D, et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 1997;126:600-7.
4. Green RH, Watson D, Buchanan S, Morrison AE. A prospective randomized concurrent comparison of the COBE Spectra. Version 4.7, COBE Spectra. Version 6 (Auto PBSC™) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and nonhaematological malignancies. Transfus Sci 2001;24:85-90.
5. Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 2001;19:108-17.
6. Hitzler WE, Wolf S, Runkel S, Kunz-Kostomanolakis M. Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies. Transfusion 2001;41:1562-6.
7. Kishimoto M, Ohto H, Shikama Y, et al. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting. Transfusion 2002;42:1340-7.
8. Goldberg SL, Mangan KF, Klumpp TR, et al. Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses. J Hematother 1995;4:85-90.
9. Anderlini P, Przepiorka D, Korbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant 1998;21(Suppl):S35-S39.
10. Uhl L, Maillet S, King S, Kruskall MS. Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 1997;37:1063-5.